Heterogeneity of Impella use in the United States for high-risk coronary interventions

Catheter Cardiovasc Interv. 2022 Jan 1;99(1):E46. doi: 10.1002/ccd.29346. Epub 2020 Oct 24.

Authors

M Chadi Alraies¹, Yasser Al-Khadra²

Affiliations

¹ Department of Interventional Cardiology, Detroit Medical Center Cardiovascular Institute, Detroit, Michigan.
² Deparment of Internal Medicine, Division of Cardiology, Southern Illinois University School of Medicine, Springfield, Illinois.

PMID: 33098364
DOI: 10.1002/ccd.29346

No abstract available

Publication types

Letter
Comment

MeSH terms

Heart-Assist Devices* / adverse effects
Humans
Shock, Cardiogenic*
Treatment Outcome
United States / epidemiology